FDA · Life Science & Pharma: GxP - CSV & Data Integrity

General Principles of Software Validation (FDA guidance)

Final CSV · Guidance Medical Device Item Related to CSV Last verified: not yet · Source last checked 3 Nov 2026

Issued by
FDA
Category
CSV
Sub Category
Guidance
Legal weight
Guidance & Q&A
Reuse
Public domain

FDA's long-standing guidance on the general principles of validating software, mainly for medical devices.

How to read this page

Details: Guide Definitions: every term and label explained

Lifecycle

Solid steps have happened. A dashed step is expected, and it is not a fact. Only dated steps in our record appear here.

  1. Done · 9 Jun 1997Draft version 1.1 dated 9 Jun 1997
  2. Done · 11 Jan 2002Version 2.0 issued, superseding the 1997 draft

In plain English

FDA guidance setting out the validation principles it considers applicable to medical device software, and to software used to design, develop or manufacture medical devices.

Summary drafted with AI assistance. Not yet reviewed by the SME Reviewer. Read the official text before acting.

Context and history

FDA's General Principles of Software Validation is the long-standing reference for software validation in the device world. Version 2.0 was issued on 11 January 2002, replacing a 1997 draft. It describes validation as establishing by objective evidence that software meets user needs and intended uses, and it explains why software needs a life cycle approach.

Its ideas spread well beyond devices, and it remains the foundation that Computer Software Assurance builds on.

Who and what it applies to

Medical device software, and software used to design, develop or make medical devices, including quality system software. It addresses device manufacturers and FDA staff.

What it contains

Section 1 Purpose
Outlines the general validation principles FDA considers applicable.
Section 2 Scope
Applicability, audience, the least burdensome approach, regulatory requirements and quality system regulation versus pre-market submissions.
Section 3 Context
Definitions, how software differs from hardware, and the benefits of validation.
Section 4 Principles
Requirements, defect prevention, time and effort, software life cycle, plans, procedures, software validation after a change, validation coverage, independence, flexibility and responsibility.
Section 5 Activities and tasks
Life cycle tasks through planning, requirements, design, construction, testing, installation, maintenance and changes.
Section 6 Automated process equipment and quality system software
Validating software used in production and quality systems, including off-the-shelf software.

Key points

  • Validation requires objective evidence that software meets user needs and intended use.
  • Software failures are usually design errors, so a life cycle approach matters.
  • Changes need validation appropriate to their risk.
  • Validation effort should match risk.
  • Independence in review is valued.
  • Users of off-the-shelf software remain responsible for validating it for their use.

In practice

General reading, not advice. This is drafted with AI and may not fit your situation. It does not replace the official text, your own quality system or qualified advice, and an inspector may take a different view.

  • Read this with CSA, since CSA changes emphasis rather than its principles.
  • Keep requirements traceable, which supports both approaches.

Read from the source document on 1 Nov 2026. This is our own description, not the official text. Check the full dated history in the change log below.

Change log

Key dated events only, not a complete history. Status after is the status once that event happened. Event kinds explained

DateEventStatus afterSource
11 Jan 2002Version 2.0 issued, superseding the 1997 draftFinalSource for Version 2.0 issued, superseding the 1997 draft
9 Jun 1997Draft version 1.1 dated 9 Jun 1997DraftSource for Draft version 1.1 dated 9 Jun 1997

How other documents connect to this one. Links explained

Compare with all linked instruments

Official source

The official text always prevails over anything on this site.

Read the official text

Source: FDA. Public domain.

Stay updated

Newsletter signup opens at launch.